Glycosaminoglycans, hyperglycemia, and disease
Linda M Hiebert1, Juying Han, Anil Kumar Mandal
11 Department of Veterinary Biomedical Sciences, Western College of Veterinary Medicine, University of Saskatchewan , Saskatoon, Canada .
Antioxidants & Redox Signaling
|November 15, 2013
Summary
Diabetes causes endothelial injury, leading to complications. Preserving heparan sulfate proteoglycans may prevent these issues by increasing endothelial heparan sulfate and reducing heparanase activity.
Area of Science:
- Endocrinology
- Vascular Biology
- Biochemistry
Background:
- Diabetes mellitus is a global health concern with increasing incidence despite pharmaceutical interventions.
- Hyperglycemia in diabetes damages endothelial cells, contributing to microvascular and macrovascular complications like nephropathy, retinopathy, neuropathy, and atherosclerosis.
- Heparan sulfate proteoglycans (HSPGs) are crucial for endothelial cell function, regulating growth and acting as reservoirs for bioactive molecules.
Purpose of the Study:
- To investigate the role of heparan sulfate proteoglycans in diabetes-induced endothelial dysfunction.
- To explore the potential of glycosaminoglycans (GAGs) and GAG-like compounds in preserving endothelial health in diabetic conditions.
- To understand the impact of hyperglycemia on heparan sulfate levels and heparanase activity.
Main Methods:
- Analysis of endothelial cell alterations in hyperglycemia.
- Assessment of heparan sulfate levels and heparanase enzyme activity.
- Evaluation of reactive oxygen species' impact on glycosaminoglycans.
Main Results:
- Hyperglycemia leads to a reduction in endothelial heparan sulfate and an increase in heparanase, an enzyme that degrades HSPGs.
- Reactive oxygen species, elevated in diabetes, further contribute to GAG degradation.
- Preserving HSPGs on endothelial cells presents a potential strategy to mitigate diabetes-associated angiopathy.
Conclusions:
- Maintaining endothelial heparan sulfate may prevent diabetic angiopathy.
- Glycosaminoglycans and GAG-like compounds show promise in increasing endothelial heparan sulfate and inhibiting heparanase.
- Further research into GAGs' role in endothelial health and heparanase modulation is crucial for developing novel diabetes treatments and preventing cardiovascular complications.
Related Concept Videos
Hyperglycemia
34
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
34
Proteoglycans
4.1K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
Complications of Diabetes Mellitus
43
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
43
Glycosaminoglycans
6.4K
Glycosaminoglycans (GAGs), also known as mucopolysaccharides, are long and linear polymers comprising of specific repeating disaccharides - the amino sugar that can be N-acetylglucosamine or N-acetylgalactosamine, and a uronic acid that is usually glucuronic acid or iduronic acid.
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
6.4K
Type I Diabetes III: Clinical Manifestations
31
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
31
Type II Diabetes II: Pathophysiology
36
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
36


